Illumina Inc (ILMN)

NASDAQ HEALTHCARE
$158.70 +5.68% RSI 79 Overbought Add Alert

Moving Averages

SMA 200
$119.08
Price above

Company Profile

Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.

Sector
HEALTHCARE
Industry
DIAGNOSTICS & RESEARCH
Market Cap
$21.47B
P/E Ratio
25.8
EPS
$5.5
Beta
1.424
Dividend Yield
0.00%
52-Week High
$155.53
52-Week Low
$77.5

Similar stocks in DIAGNOSTICS & RESEARCH

Data last updated: May 12, 2026 at 4:13 AM EDT

Track ILMN for free

Get e-mail RSI alerts when Illumina Inc enters oversold or overbought territory. Free forever.

Add Alert